Oxybutynin Chloride Tablet, Extended Release
Product Images NDC 72189-132

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 72189-132). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct Rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

13230 (72189 0132 30)

This is a medication containing Oxybutynin Chloride ER. It is a generic version of Ditropan XL which is used to treat the symptoms of an overactive bladder (urgency, frequency, or leakage). It comes in extended-release tablet form, with 10mg of Oxybutynin Chloride USP. The medication comes in a 30-day supply. There are several lots of this medication with different expiration dates and lot numbers. The manufacturer of this medication is Accord Healthcare Inc., located in Durham, NC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.